WallStreetZenWallStreetZen

NASDAQ: PLSE
Pulse Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for PLSE

Based on 1 analyst offering 12 month price targets for Pulse Biosciences Inc

Min Forecast
$22.00+42.3%
Avg Forecast
$22.00+42.3%
Max Forecast
$22.00+42.3%

Should I buy or sell PLSE stock?

Based on 1 analyst offering ratings for Pulse Biosciences Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although PLSE's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates PLSE as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their PLSE stock forecasts and price targets.

PLSE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-07-07

1 of 1

Forecast return on equity

Is PLSE forecast to generate an efficient return?

Company
-94.57%
Industry
17.12%
Market
326.44%
PLSE's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PLSE forecast to generate an efficient return on assets?

Company
-82.18%
Industry
13.08%
PLSE is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PLSE earnings per share forecast

What is PLSE's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$1.19
Avg 2 year Forecast
-$1.47

PLSE revenue forecast

What is PLSE's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$1.3M
Avg 2 year Forecast
$10.2M

PLSE vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
PLSE$15.73$22.00+39.86%Buy
BLFS$27.02$32.00+18.43%Buy
STAA$26.63$25.50-4.24%Hold
EMBC$13.46$18.50+37.44%Buy
KMTS$26.10$27.00+3.45%Strong Buy
View Top Medical Stocks

Pulse Biosciences Stock Forecast FAQ

Is Pulse Biosciences Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: PLSE) stock is to Buy PLSE stock.

Out of 1 analyst, 0 (0%) are recommending PLSE as a Strong Buy, 1 (100%) are recommending PLSE as a Buy, 0 (0%) are recommending PLSE as a Hold, 0 (0%) are recommending PLSE as a Sell, and 0 (0%) are recommending PLSE as a Strong Sell.

If you're new to stock investing, here's how to buy Pulse Biosciences stock.

What is PLSE's earnings growth forecast for 2025-2026?

(NASDAQ: PLSE) Pulse Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 205.18%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,853.38%.

Pulse Biosciences's earnings in 2025 is -$68,028,000.On average, 3 Wall Street analysts forecast PLSE's earnings for 2025 to be -$80,289,979, with the lowest PLSE earnings forecast at -$77,141,353, and the highest PLSE earnings forecast at -$82,651,449.

In 2026, PLSE is forecast to generate -$98,818,436 in earnings, with the lowest earnings forecast at -$94,943,203 and the highest earnings forecast at -$101,724,861.

What is PLSE's revenue growth forecast for 2025-2026?

(NASDAQ: PLSE) Pulse Biosciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 5.05%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,422.63%.

Pulse Biosciences's revenue in 2025 is $0.On average, 3 Wall Street analysts forecast PLSE's revenue for 2025 to be $85,779,892, with the lowest PLSE revenue forecast at $82,415,975, and the highest PLSE revenue forecast at $88,336,470.

In 2026, PLSE is forecast to generate $686,239,139 in revenue, with the lowest revenue forecast at $659,327,801 and the highest revenue forecast at $706,422,644.

What is PLSE's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: PLSE) forecast ROA is -82.18%, which is lower than the forecast US Medical Instruments & Supplies industry average of 13.04%.

What is PLSE's Price Target?

According to 1 Wall Street analyst that have issued a 1 year PLSE price target, the average PLSE price target is $22.00, with the highest PLSE stock price forecast at $22.00 and the lowest PLSE stock price forecast at $22.00.

The Wall Street analyst predicted that Pulse Biosciences's share price could reach $22.00 by Jul 7, 2026. The average Pulse Biosciences stock price prediction forecasts a potential upside of 39.86% from the current PLSE share price of $15.73.

What is PLSE's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: PLSE) Pulse Biosciences's current Earnings Per Share (EPS) is -$1.06. On average, analysts forecast that PLSE's EPS will be -$1.19 for 2025, with the lowest EPS forecast at -$1.15, and the highest EPS forecast at -$1.23. In 2026, PLSE's EPS is forecast to hit -$1.47 (min: -$1.41, max: -$1.51).

What is PLSE's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: PLSE) forecast ROE is -94.57%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.